Alkermes
ALKS
#3093
Rank
NZ$8.43 B
Marketcap
NZ$51.10
Share price
0.75%
Change (1 day)
-5.16%
Change (1 year)

Alkermes (ALKS) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.12 Billion

According to Alkermes's latest financial reports the company's total debt is NZ$0.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Alkermes - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.13 B-77.24%
2023-12-31NZ$0.58 B-1.52%
2022-12-31NZ$0.59 B-1.92%
2021-12-31NZ$0.60 B7.19%
2020-12-31NZ$0.56 B31.58%
2019-12-31NZ$0.43 B3.75%
2018-12-31NZ$0.41 B5.08%
2017-12-31NZ$0.39 B-3.23%
2016-12-31NZ$0.40 B-19.91%
2015-12-31NZ$0.51 B12.61%
2014-12-31NZ$0.45 B
2013-03-31NZ$0.44 B-18.64%
2012-03-31NZ$0.54 B
2010-03-31NZ$72.11 M-46.12%
2009-03-31NZ$0.13 B-32.9%
2008-03-31NZ$0.19 B-9.93%
2007-03-31NZ$0.22 B-52.37%
2006-03-31NZ$0.46 B19.15%
2005-03-31NZ$0.39 B104.6%
2004-03-31NZ$0.19 B-39.44%
2003-03-31NZ$0.31 B-37.43%
2002-03-31NZ$0.50 B-10.28%
2001-03-31NZ$0.56 B21.52%
2000-03-31NZ$0.46 B531.42%
1999-03-31NZ$73.11 M130.3%
1998-03-31NZ$31.74 M52.51%
1997-03-31NZ$20.81 M11.39%
1996-03-31NZ$18.68 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Acorda Therapeutics
ACOR
NZ$0.33 B 173.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.35 B 71,188.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.27 B 63,861.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.32 B 84,885.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$56.48 B 45,476.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 23,745.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.19 B 35,559.24%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$55.43 B 44,624.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland